Kong (2007) |
Canada |
1984–2001 |
44,223 RT courses to bone |
34.4% of RT courses were SFRT |
[14] |
Sutton (2006) |
Canada |
1984–2004 |
Patients who died of cancer between 1984–2004; 236,078 RT courses to bone delivered with palliative intent |
In last 2 years of life: 30% were SFRT, 44% were five fractions, 11% were 10 fractions |
[15] |
Ashworth (2014) |
Canada |
1984–2012 |
186,694 Palliative RT courses to bone |
41.3% of RT courses were SFRT |
[24] |
Danjoux (2006) |
Canada |
1996–2003 |
2989 RT courses to bone |
Single 8-Gy fraction in 45%, 20 Gy in five fractions in 42%, 30 Gy in 10 fractions in 4% |
[16] |
Haddad (2005) |
Canada |
1998–2002 |
882 RT courses to bone |
32% of courses were SFRT |
[17] |
Bradley (2008) |
Canada |
1999–2005 |
965 RT courses to bone |
65% of patients received SFRT |
[18] |
Naidoo (2011) |
Canada |
2000–2010 |
17,682 Patients, 42% of which were referred for bone metastases |
20 Gy/5 fractions was most common, used to treat 59% of bone metastases SFRT used to treat bone metastases in 35% of patients |
[19] |
Wu (2010) |
Canada |
2003–2005 |
1354 RT courses to bone |
SFRT was prescribed in 57% of patients who went to rapid access clinic and 33% of patients who went to regular care |
[20] |
Thavarajah (2013) |
Canada |
2005–2012 |
2549 Courses of RT to patients with bone metastases |
65% of RT courses were SFRT |
[21] |
Potter (2009) |
Canada |
2007–2008 |
422 RT courses to bone metastases in 389 patients |
Of 137 patients with uncomplicated bone pain, 48.9% were treated with SFRT |
[22] |
Olson (2014) |
Canada |
2007–2011 |
16,898 Total courses of RT to 8601 patients |
49.2% SFRT; More than 10 fractions were prescribed to only 0.2% of patients |
[23] |
Foro Arnalot (2010) |
Spain |
1990–2009 |
3042 Palliative treatments, 78.14% of which were to bone |
46.85% of courses were SFRT from 1990 to 1996, 49.25% were SFRT from 1999 to 2009 |
[25] |
Szostakiewicz (2004) |
Poland |
1995–2002 |
1165 Patients irradiated to 1754 bone metastases |
19% of patients treated with SFRT |
[26] |
Laughsand (2013) |
Norway |
1997–2007 |
Patients treated with either 8 Gy/1 fraction or 30 Gy/10 fractions to bone metastases; 14,380 RT courses to bone metastases total |
SFRT delivered to 31.3% of patients |
[27] |
Santacaterina (2004) |
Italy |
2000 |
325 Patients treated to 458 bone metastases |
257 (79%) of patients were treated with MFRT (30 Gy/10 fractions) |
[28] |
Bhalla (2012) |
United Kingdom |
2000 and 2006 |
120 Patients per year who received palliative radiation therapy to bone metastases |
SFRT was prescribed in 42% of patients in 2000 and 40% in 2006 |
[29] |
Moller (2003) |
Sweden |
Sept–Dec 2001 |
A total of 1144 irradiated sites of bone metastases |
SFRT used in 37% of treatment sites |
[30] |
Williams (2006) |
United Kingdom |
One week, starting Sept 29, 2003 |
Palliative radiotherapy given to 43% of 2498 patients (exact number for bone metastases not provided) |
SFRT was the most common prescription, followed by 20 Gy in 5 fractions |
[32] |
van Oorschot (2011) |
Germany |
1 month in 2008 |
62 Patients were treated to bone metastases |
Of 18 patients who were treated to bone metastases with the intent of pain relief, only 2 received SFRT. Most common fractionation was 30 Gy/10 fractions for bone metastases |
[31] |
Chen (2013) |
United States |
2003–2005 |
194 Patients with lung cancer who received radiation treatment to bone |
50% Received 6–10 fractions, 20% received five fractions or lower, 6% received a single fraction |
[33] |
Beriwal (2012) |
United States |
2003–2010 |
7905 Sites of bone metastases treated with RT |
37.8% of patients received 1–5 fractions. Single-fraction was chosen for palliation in 13.5% of cases at academic centers, and 3.9% at community centers |
[34] |
Bekelman (2013) |
United States |
2006–2009 |
3050 Patients treated with palliative RT to bone |
3.3% were treated with SFRT. When previously documented complicated bone metastases were excluded, 3.8% of 2028 patients were treated with SFRT |
[36] |
Bekelman (2014) |
United States |
2006–2012 |
5160 Patients treated with palliative RT to bone |
4.0% were treated with SFRT. When previously documented complicated bone metastases were excluded, 4.1% of 4006 patients were treated with SFRT |
[38] |
Ellsworth (2014) |
United States |
2007–2012 |
339 Patients whose final RT was for bone metastases |
8% Received SFRT 83% of patients were prescribed less than or equal to 10 fractions |
[37] |
Hess (2012) |
United States |
2008–2009 |
207 and 213 breast and prostate cancer patients treated with palliative RT to bone |
Majority of patients received at least 10 fractions |
[35] |
Holt (2010) |
Australia |
May–October 2005 |
77 and 207 RT courses for bone metastases at the rapid response clinic and regular care, respectively |
75% and 58% of patients were treated with SFRT to bone at the rapid response clinic and regular care, respectively |
[39] |